Constraints and number of mentions (total and by diagnostic group)
| Constraints | NF1 | PSC | PAH | MFS | Total N |
| Shared aspects named by two diagnostic groups | |||||
| Constraints in daily life | 3 | 8 | 11 | ||
| Shared aspects named by all four diagnostic groups | |||||
| Constraints in personal and social life | 4 | 9 | 7 | 5 | 25 |
| Constraints in professional life | 9 | 4 | 3 | 6 | 22 |
Numbers represent the total number of mentions and are displayed for each diagnosis individually as well as across all diagnostic groups; grey cells represent categories, which were mentioned at least once in a diagnostic group.
MFS, Marfan syndrome; NF1, neurofibromatosis type 1; PAH, pulmonary arterial hypertension; PSC, primary sclerosing cholangitis.